D. J. Meiklejohn - Concepedia

Author

D. J. Meiklejohn

Also Known As

D Meiklejohn, D. J. Meiklejohn, D. MeikleJohn, D. Meiklejohn, D.J. MEIKLEJOHN, D.J. Meiklejohn, David J. Meiklejohn, David Meiklejohn, Meiklejohn, David J.

Publications

615

Citations

H-Index

Concepts

All Affiliations

University of Aberdeen NHS Grampian Aberdeen Royal Infirmary Ninewells Hospital

About

D. J. Meiklejohn is an author at University of Aberdeen specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	117
2	Health Sciences	2	2	27
3	Public Health	1	1	39
4	Clinical Nutrition	1	1	10
5	Gastroenterology	1	1	10

D. J. Meiklejohn

Publications

561

Citations

H-Index

Page 1

	Year	Citations
Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study Kathleen Beusterien, John Davies, M.J. Leach, Health and Quality of Life Outcomes	2010	107
Plasma Homocysteine Concentrations in the Acute and Convalescent Periods of Atherothrombotic Stroke D. J. Meiklejohn, Mark A. Vickers, R. Dijkhuisen, Stroke	2001	84
Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population Mary Joan MacLeod, R. P. De Lange, Gerome Breen, European Journal of Clinical Investigation	2001	62
<i>C-MYC</i>translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator? Lesley Christie, Neil Kernohan, David Levison, Leukemia & lymphoma/Leukemia and lymphoma C-myc TranslocationsImmunologyPathologyImmunotherapyC-myc Translocation	2008	51
No association between Glu/Asp polymorphism of <i>NOS3</i> gene and ischemic stroke Mary Joan MacLeod, Mohammed Dahiyat, Alistair Cumming, Neurology	1999	51
<i>In vivo</i> platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib D. J. Meiklejohn, Mark A. Vickers, E. R. Morrison, British Journal of Haematology	2001	50
Acquired haemophilia in association with organ‐specific autoimmune disease D. J. Meiklejohn, Henry G. Watson Haemophilia	2001	44
Platelet glycoprotein IIIa polymorphism HPA 1b (Pl<sup>A2</sup>): no association with platelet fibrinogen binding D. J. Meiklejohn, S. J. Urbaniak, M. Greaves British Journal of Haematology Genetic EpidemiologyImmunologyPathologyPlatelet PathobiologyMolecular Biology	1999	39
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman, Journal of Clinical Oncology	2024	31
The relationships of ABO, Lewis and Secretor blood groups with cerebral ischaemia of arterial origin Peter Clark, D. J. Meiklejohn, A. F. O'SULLIVAN, Journal of Thrombosis and Haemostasis Secretor Blood GroupsMedicinePhysiologyHematologyCerebral Ischaemia	2005	17

Page 1